Actual Medicinal Product (AMP) Venlalic XL 225mg tablets (Waymade Healthcare Plc)

This product can't be added to an MCA list.

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Moisture sensitive medicine. Store in airtight container. Manufacturer recommends storage in original container. Original packaging may contain desiccant. Anecdotal reports of use in MCAs (low quality evidence)

Provenance

This recommendation is based on the products Venlalic 225mg prolonged release tablets (Martindale Pharma, an Ethypharm Group Company and Venlafaxine 225mg prolonged release tablets (Ranbaxy (UK) Limited a Sun Pharmaceutical Company).

Generic
Venlafaxine
Formulation
Venlafaxine 225mg modified-release tablets
  • Venlafaxine
    • Venlafaxine 225mg modified-release tablets

      • Venlalic XL 225mg tablets (Waymade Healthcare Plc)